SII

Serum Institute to produce additional 100 million COVID-19 vaccine doses

Serum Institute to produce additional 100 million COVID-19 vaccine doses

The Serum Institute of India (SII) on Tuesday said that it will produce additional 100 million COVID-19 vaccine doses for India and low a...Read More

COVID-19 vaccine update: Serum Institute CEO Adar Poonawalla warns of shortage of the COVID-19 vaccine for all till 2024

COVID-19 vaccine update: Serum Institute CEO Adar Poonawalla warns of shortage of the COVID-19 vaccine for all till 2024

The CEO of the Serum Institute of India (SII) Adar Poonawalla has warned of shortage of the COVID-19 vaccine for all till 2024.In an inte...Read More

Serum Institute gets DCGI notice over Oxford COVID-19 vaccine trial suspension by AstraZeneca

Serum Institute gets DCGI notice over Oxford COVID-19 vaccine trial suspension by AstraZeneca

The central drug regulator has issued a show-cause notice to Serum Institute of India (SII) for not informing it about pharma giant Astra...Read More

Adar Poonawalla breaks silence on SII -Covishield clinical trials; says 'stay patient for two months'

Adar Poonawalla breaks silence on SII -Covishield clinical trials; says 'stay patient for two months'

On Thursday, Serum Institute of India CEO Adar Poonawalla asked the media to refrain from reporting on data coming in about patients on S...Read More

'Pearl & pride of Pune': Twitter lauds Serum Institute for partnering with Bill Gates Foundation, Gavi for COVID-19 vaccine

'Pearl & pride of Pune': Twitter lauds Serum Institute for partnering with Bill Gates Foundation, Gavi for COVID-19 vaccine

Serum Institute of India (SII) on Friday said it has entered into a new partnership with international vaccine alliance Gavi and Bill &a...Read More

Latest Coronavirus Vaccine Update: Serum Institute of India expects COVID-19 vaccine by year-end

Latest Coronavirus Vaccine Update: Serum Institute of India expects COVID-19 vaccine by year-end

Vaccine maker Serum Institute of India (SII) is hoping to develop a COVID-19 vaccine by the year-end as it is focusing on a "good and saf...Read More

Free Press Journal

www.freepressjournal.in